James Aloysius Brady - 28 Mar 2025 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht, Attorney-in-Fact
Issuer symbol
XERS
Transactions as of
28 Mar 2025
Net transactions value
$0
Form type
3
Filing time
28 Mar 2025, 16:44:04 UTC
Previous filing
30 Apr 2024
Next filing
29 Apr 2025

No securities are beneficially owned.